Immunotherapeutic approaches of rheumatic disorders.
Houssiau
F A
FA
Rheumatology Department, Saint-Luc University Hospital, Louvain Medical School, Brussels, Belgium.
Lauwerys
B R
BR
D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D019013:CD40 Antigens / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D007375:Interleukin-1 / Q000037:antagonists & inhibitors* / Q000276:immunology; D016753:Interleukin-10 / Q000037:antagonists & inhibitors* / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
D019013:CD40 Antigens; D007375:Interleukin-1; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10